FDA To Hold COX-2 Advisory Committee In Early 2005, Woodcock Says

The agency will have to make a trade-off between getting products on the market and determining their cardiovascular safety profile. Merck believes placebo-controlled trials in osteoarthritis patients should not be longer than four months due to ethical concerns.